SHS exits its interest in Novosis
SHS, together with co-investors, has sold its remaining shares in German therapeutic plasters and implants developer Novosis to the Schweizerhall Group for an undisclosed sum.
SHS, together with co-investors, has sold its remaining shares in German therapeutic plasters and implants developer Novosis to the Schweizerhall Group for an undisclosed sum.